Morgan Cantley, PharmD, BCOP
Advertisement
Articles by Morgan Cantley, PharmD, BCOP
Morgan Cantley, PharmD, BCOP, shares key insights about the HER2-targeting antibody-drug conjugate trastuzumab deruxtecan.
Advertisement
Latest Updated Articles
Trastuzumab and HER2-Targeted Therapy: Breaking Down the BasicsPublished: August 15th 2025 | Updated:
- Expert Highlights Advances in HER2-Directed Therapies Beyond HER2-Positive Disease
Published: August 18th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants National Priority Vouchers to Enlicitide Decanoate, Sacituzumab Tirumotecan
2
Bepirovirsen Shows Breakthrough Potential for Functional Cure in Chronic Hepatitis B
3
Surveys Find Significant Gaps in Public’s Understanding of Shared Decision-Making on Vaccinations
4
Statins in T2D Reduce Mortality, Major CVD Across Spectrum of Cardiovascular Risk
5